Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation is a research paper published in Brain Behavior & Immunity - Health (2020). On theSindex it has a DataRank of 0.515. It has been cited 30 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.515
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NINDS NIH HHS
Grant: R01 NS097776
NIA NIH HHS
Grant: U01 AG052460
NINDS NIH HHS
Grant: R01 NS112308
National Institutes of Health
Grant: 3U01AG052460-04S1
Development of EP2 receptor antagonists for suppression of Alzheimer's neuropathology
National Institutes of Health
Grant: 1R01NS112308-01A1
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
National Institutes of Health
Grant: 5R01NS097776-02
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures
National Institutes of Health
FWCI
0.93
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals